Recent Faculty Publications

Oubraim S, Fauzan M, Studholme K, Gordon C, Glaser ST, Shen RY, Ojima I, Kaczocha M, Haj-Dahmane S. (2025) Astrocytic FABP5 mediates retrograde endocannabinoid transport at central synapses. iScience (May), 28(5): 112342. doi:10.1016/j.isci.2025.112342
Oubraim S, Hausknecht K, Micov V, Shen RY, Haj-Dahmane S. (2025) Chemogenetic inhibition of prefrontal cortex inputs to dorsal raphe reduces anxiety behaviors in male rat model of fetal alcohol spectrum disorder. Scientific reports (Apr), 15(1): 14397. doi:10.1038/s41598-025-99181-8
Lynn MB, Geddes SD, Chahrour M, Maillé S, Caya-Bissonnette L, Harkin E, Harvey-Girard É, Haj-Dahmane S, Naud R, Béïque JC. (2025) Nonlinear recurrent inhibition through facilitating serotonin release in the raphe. Nature neuroscience (Apr).
Sharafshah A, Lewandrowski KU, Gold MS, Fuehrlein B, Ashford JW, Thanos PK, Wang GJ, Hanna C, Cadet JL, Gardner EL, Khalsa JH, Braverman ER, Baron D, Elman I, Dennen CA, Bowirrat A, Pinhasov A, Modestino EJ, Carney PR, Cortese R, Fiorelli RKA, Schmidt S, Pollack AR, Badgaiyan RD, Blum K. (2025) In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder. Current neuropharmacology (Jan).
Lu H, Roeder N, Richardson B, Hamilton J, Sharma A, Owada Y, Kagawa Y, Thanos P. (2025) Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding. Neuroscience letters (Jan), 844: 138040.
Finnell JE, Ferrario CR. (2025) Voluntary food restriction does not affect circulating corticosterone in obesity-prone or -resistant male and female rats. Physiology & behavior (Jan), 288: 114729.
Green RP, Blum K, Lewandrowski KU, Gold MS, Lewandrowski APL, Thanos PK, Dennen CA, Baron D, Elman I, Sharafshah A, Modestino EJ, Badgaiyan RD. (2025) Letter to the Editor. Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk. Substance abuse and rehabilitation (Jan), 16: 23-26. doi:10.2147/SAR.S514931
Sunder K, Makale MT, Makale M, Bodhanapati J, Murphy KT, Dennen CA, Baron D, Thanos PK, Hanna C, Ashford JW, Lewandrowski KU, Blum K. (2025) Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series. Psychology research and behavior management (Jan), 18: 225-240. doi:10.2147/PRBM.S482960
Wang R, Martin CD, Lei AL, Hausknecht KA, Richards JB, Haj-Dahmane S, Shen RY. (2025) Environmental enrichment reverses prenatal ethanol exposure-induced attention-deficits in rats. Frontiers in psychiatry (Jan), 16: 1549318. doi:10.3389/fpsyt.2025.1549318
Blum K, Bowirrat A, Thanos PK, Hanna C, Khalsa J, Baron D, Elman I, Badgaiyan RD, Dennen C, Braverman ER, Carney P, Lewandrowski KU, Sharafshah A, Gold MS. (2024) Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction. EC psychology and psychiatry (Dec), 13(1): 1-3.
Martin MK, Rodriguez R, Guerrero G, Sheehan GD, Powell R, Klein AH, Bhattacharjee A. (2024) Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain. Pain (Nov).
Costa PC, Salinas B, Wojciechowski A, Wood SK, Runyon S, Clark SD. (2024) The Influence of the Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors. The Journal of pharmacology and experimental therapeutics (Nov), 391(3): 460-471. doi:10.1124/jpet.124.002415
Lewter LA, Woodhouse K, Tiruveedhula VVNPB, Cook JM, Li JX. (2024) Antinociceptive Effects of a2/a3-Subtype-Selective GABAA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity. The Journal of pharmacology and experimental therapeutics (Nov), 391(3): 389-398. doi:10.1124/jpet.123.002070
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024) Correction: Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats.
Molly K Martin MK, Rodriguez R, Guerrero G, Sheehan GD, Powell R, Klein AH, Bhattacharjee A. (2024) Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain. Pain (Nov) doi:10.1097/j.pain.0000000000003470
Peng L, Zhang J, Feng J, Ge J, Zou Y, Chen Y, Xu L, Zeng Y, Li JX, Liu J. (2024) Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms. Biochemical pharmacology (Oct), 228: 116236.
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024) Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats. Molecular neurobiology (Oct).
Collins RL, Thanos PK, Ashare R, Herzberg D, Silverman R. (2024) Effects of the Federal Government's Move to Reschedule Cannabis: A Commentary. Journal of studies on alcohol and drugs (Oct).
Cooper JJM, Muthaiah R, Frost JR, Buck GT, Ravichandar R, Gadelkarim F, Raymond FD, Sim FJ. (2024) Clemastine Induces Oligodendrocyte Progenitor Pool Exhaustion and Senescence in the Context of Chronic Demyelination in a Rabbit Model. Annals of neurology (Oct).
Smith Z, Cheli VT, Angeliu CG, Wang C, Denaroso GE, Tumuluri SG, Corral J, Garbarini K, Paez PM. (2024) Ferritin loss in astrocytes reduces spinal cord oxidative stress and demyelination in the experimental autoimmune encephalomyelitis (EAE) model. Glia (Sep).